192 related articles for article (PubMed ID: 9404422)
21. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
22. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
23. Does insulin release kinins in rats?
Damas J; Garbacki N; Lefèbvre PJ
Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
25. Role of kinins in the endothelial protective effect of ischaemic preconditioning.
Bouchard JF; Chouinard J; Lamontagne D
Br J Pharmacol; 1998 Feb; 123(3):413-20. PubMed ID: 9504381
[TBL] [Abstract][Full Text] [Related]
26. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
27. Renal haemodynamic effects of B2 receptor agonist bradykinin and B2 receptor antagonist HOE 140 in conscious lambs.
Patel A; Smith FG
Exp Physiol; 2000 Nov; 85(6):811-7. PubMed ID: 11187975
[TBL] [Abstract][Full Text] [Related]
28. Kinin B2 receptor-mediated contraction of tail arteries from normal or streptozotocin-induced diabetic rats.
Wang Z; Wu L; Wang R
Br J Pharmacol; 1998 Sep; 125(1):143-51. PubMed ID: 9776354
[TBL] [Abstract][Full Text] [Related]
29. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
Persson K; Andersson RG
J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
Chalon S; Moreno H; Hoffman BB; Blaschke TF
Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
[TBL] [Abstract][Full Text] [Related]
31. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
32. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
33. Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
Hajj-Ali AF; Zimmerman BG
J Pharmacol Exp Ther; 1992 Oct; 263(1):158-62. PubMed ID: 1328603
[TBL] [Abstract][Full Text] [Related]
34. Effect of neutral endopeptidase inhibition on vascular response induced by exogenous angiotensin I in the isolated rat lung.
Bartuś JB; Chłopicki S
Pol J Pharmacol; 2003; 55(6):1071-8. PubMed ID: 14730103
[TBL] [Abstract][Full Text] [Related]
35. Bradykinin-induced contractions of canine saphenous veins: mediation by B2 receptors and involvement of eicosanoids.
Marsault R; Illiano S; Vanhoutte PM
Br J Pharmacol; 1997 Jan; 120(2):215-20. PubMed ID: 9117112
[TBL] [Abstract][Full Text] [Related]
36. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.
Wille PR; Vitor R; Gabilan NH; Nicolau M
Mediators Inflamm; 2001 Jun; 10(3):163-7. PubMed ID: 11545253
[TBL] [Abstract][Full Text] [Related]
37. [Do renal vascular D2 receptors exist?].
Barthelmebs M; Krieger JP; Grima M; Imbs JL
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1211-3. PubMed ID: 1953269
[TBL] [Abstract][Full Text] [Related]
38. Kallistatin is a potent new vasodilator.
Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical action of desipramine on the modulatory effect of bradykinin on noradrenaline release in a model of metabolic anoxia in rat isolated atria.
Foucart S; Grondin L; Couture R; Nadeau R
Can J Physiol Pharmacol; 1997 Jun; 75(6):646-51. PubMed ID: 9276143
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
